Skip to content

The Effect of Acupressure and Reiki on Pain and Fatigue Levels

The Effect of Acupressure and Reiki on Pain and Fatigue Levels in Cancer Patients Receiving Palliative Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05473845
Enrollment
156
Registered
2022-07-26
Start date
2022-02-11
Completion date
2022-07-21
Last updated
2022-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupressure, Cancer Pain, Fatigue

Brief summary

This research was conducted with the aim of determining the effect of levels of pain and fatigue of acupressure and Reiki application on cancer patients receiving palliative care. The research was a single-blind, repeated measures, randomized controlled study. Research data were collected between February and July 2022. The research sample consisted of acupressure and Reiki application groups and a control group with 52 patients in each group, a total of 156 patients. Data was collected by means of a Patient Description Form, an Analgesic Follow-up Form, the Eastern Cooperative Oncology Group Performance Status Scale, the Numeric Pain Rating Scale, and the Brief Fatigue Inventory.

Interventions

Acupressure

Reiki

Sponsors

Mardin Artuklu University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. having a diagnosis of third or fourth-stage cancer, 2. being aged 18 years or older, 3. having had pain for at least one month in connection with cancer treatment or the symptoms of the disease, 4. using NSAII or non-opioid analgesics, 5. having a status of 3 or more on the Numeric Pain Rating Scale (NPRS), 6. having a score of 0-3 on the ECOG-PS scale

Exclusion criteria

1. having a diagnosis of first or second-stage cancer, 2. being aged less than 18 years, 3. having bone or brain metastasis, 4. using opioid analgesics, 5. having a status of less than 3 on the NPRS, 6. having a status of between 4 and 5 on the ECOG-PS scale

Design outcomes

Primary

MeasureTime frameDescription
Numeric Pain Rating Scaleon the second day of the starting weekA score of 0 indicates no pain, 1-3 slight pain, 4-6 moderate pain, and 7-10 severe pain .
Brief Fatigue Inventoryon the second day of the starting weekIt is scored between 0 and 10.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026